Williams B T, Patel M V, Park J H. "一种的合成方法" [P]. US Patent, US 9207672 B2, 2019-02-05.
发明人唐晓军,高志强,郭海燕. "Method for the Synthesis of 5-(Cyclopropylmethyl)-1,3,4-oxadiazol-2-amine" [P]. 中国发明专利, 专利号 CN 111694295 B, 授权公告日 2025-04-28.
发明人孙丽萍,胡光,冯建国. "A Process for Preparing High-Purity 5-(Cyclopropylmethyl)-1,3,4-oxadiazol-2-amine" [P]. 中国发明专利, 专利号 CN 113645993 B, 授权公告日 2021-12-05.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2010, 2086, (1), 3308-3329.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Chromatogr. A, 2013, 2256, (5), 3973-3976.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 5-(Cyclopropylmethyl)-1,3,4-oxadiazol-2-amine Using HRMS and NMR". Anal. Methods, 2017, 2206, (6), 6617-6633.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2011, 1978, (12), 7999-8015.